Translational Medicine: Pharmaceutical Cancer (Master of Research) - suspended

Note that due to unanticipated circumstances, Translational Medicine, Pharmaceutical Cancer will not be accepting entrants for 2012 intake. Interested individuals may wish to apply instead for the related Masters of Research in Translational Medicine, Interdisciplinary Molecular Medicine:

• Translational Medicine: Interdisciplinary Molecular Medicine (MRes)

• University of Manchester ranked 3rd in the UK for Research Power for the number of world-leading or internationally excellent research staff, and judged the leading UK University for cancer research (RAE 2008)
• Extensive (35 week) research placements provide opportunity to conduct ambitious projects - often resulting in published work
• Around 65% of our graduates progress into PhD training or a career in the Pharmaceutical industry, 15% are intercalating medics and approximately 10% pursue an undergraduate medical degree
• Profiles of academic staff who contribute to the course
• Strong links with AstraZeneca Pharmaceutical company, and individual modules available for Continuous Professional Development

Applying online
Instructions and guidance notes for applying online

What is Translational Medicine, and what do current students think of the MRes?

View all video clips

• Using silk as a biomaterial for nerve regeneration
• Species variability in metabolism as a translational factor influencing susceptibility to adverse drug reactions in man
• The function of Notch signalling in vascular smooth muscle cell differentiation from mouse embryonic stem cells
• Statins in translational cerebral ischemia: systematic review and meta-analysis of pre-clinical studies
• Parallel gene expression profiling and histological analysis of tumour tissue microarrays
• Research Project Outputs and further research project examples

This Masters of Research, with its extended 35 week research project, links with AstraZeneca and strong focus on cancer drug safety and therapeutics, provides an excellent platform to progress into PhD research, or for a career in the Pharmaceutical or Biotechnology Industries.

• More than 50% of our graduates progress into PhD research (within e.g. the Universities of Manchester, Cambridge, Imperial College London, Newcastle, Glasgow, Liverpool, Bristol)
• Around 10% pursue a career in the Pharmaceutical or Biotechnology industry (UK or abroad), often through contacts made on the course
• Approximately 15% are intercalating medics who complete their medical education
• An estimated 10% pursue an undergraduate medical degree